(NEW YORK) -- Moderna announced Tuesday it has dosed its first participant in a phase III clinical trial of a combination influenza and COVID-19 vaccine.This phase will evaluate the safety and efficacy of the combo vaccine compared to flu and COVID vaccines that are... Read More.
(NEW YORK) -- Moderna will keep its COVID vaccine on the market at no cost to consumers, even after the federal government stops paying for it, the company announced Wednesday."Everyone in the United States will have access to Moderna's COVID-19 vaccine regardless of their... Read More.
(NEW YORK) -- Moderna's respiratory syncytial virus, or RSV, vaccine for older adults was about 84% effective at preventing serious illness, according to data from a late-stage trial published Tuesday.Adult patients in the clinical trial appeared to tolerate the vaccine well and there were... Read More.
(NEW YORK) -- American biotechnology company Moderna announced Monday that a booster dose of its bivalent COVID-19 vaccine performs better against two circulating versions of the omicron variant, compared with a booster shot of its original formula.The news echoes a similar announcement made earlier... Read More.
(NEW YORK) -- Moderna is suing Pfizer and BioNTech for infringing patents central to Moderna's mRNA technology platform used to develop the COVID vaccine, the company said in a press release Friday.A widely distributed COVID vaccine developed by Pfizer and BioNTech, called Comirnaty, infringes... Read More.
(CAMBRIDGE, Mass.) -- Amid growing concerns over the potential threat of monkeypox, executives from Moderna said Wednesday they have initiated a research program to consider whether the company could create a monkeypox vaccine with mRNA technology."We're obviously very aware of the monkeypox concern and... Read More.
(ATLANTA) -- A committee of advisers at the Centers for Disease Control and Prevention voted unanimously Thursday to greenlight the Moderna COVID-19 vaccine for kids ages 6 to 17, clearing the way for parents to have one more vaccine to choose from when considering... Read More.
(NEW YORK) -- A panel of advisers at the Centers for Disease Control have greenlit the Pfizer and Moderna COVID-19 vaccines for kids as young as 6 months old, finding them both safe and effective.CDC Director Rochelle Walensky issued a recommendation for how doctors, nurses... Read More.
(WASHINGTON) -- The Food and Drug Administration has authorized the Pfizer and Moderna COVID-19 vaccines for kids as young as six months old, finding them both safe and effective."Many parents, caregivers and clinicians have been waiting for a vaccine for younger children and this... Read More.
(WASHINGTON) -- Parents with young kids are one step closer to getting them vaccinated following a grueling wait for the last remaining group to be authorized for a vaccine.The process for authorization and recommendation from the regulatory agencies kicked off Wednesday with a meeting... Read More.
(WASHINGTON) -- A committee of advisers at the Food and Drug Administration voted unanimously Tuesday in favor of authorizing the Moderna vaccine for kids ages 6 through 17, paving the way to add one more vaccine to the options available for this age group.Currently,... Read More.
(NEW YORK) -- With vaccine immunity waning, and concerns over a fall surge growing, officials from Moderna announced on Wednesday that data from its study on Omicron-containing bivalent booster, revealed that it offers superior antibody response against omicron -- one month after injection --... Read More.